Drug Type Small molecule drug |
Synonyms HIF-PH inhibitor + [2] |
Target |
Action inhibitors |
Mechanism HIF-PHs inhibitors(Hypoxia-inducible factor prolyl hydroxylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Start Date12 Mar 2025 |
Sponsor / Collaborator |
Start Date12 Dec 2022 |
Sponsor / Collaborator |
Start Date20 Oct 2022 |
Sponsor / Collaborator |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Anemia of renal disease | Phase 2 | China | 12 Dec 2022 | |
Chronic Kidney Diseases | Phase 2 | China | 12 Dec 2022 | |
Nephrosis | Phase 1 | China | 30 Jan 2022 | |
Anemia in chronic kidney disease | Phase 1 | China | 01 May 2020 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |